Atezolizumab in combination for untreated squamous non-small-cell lung cancer [ID1481]

  • Discontinued
  • GID-TA10546
The company has informed NICE that it will not provide an evidence submission for this appraisal. Therefore, we are suspending the appraisal while we consider the next steps